Valneva SE (INRLF)
OTCMKTS · Delayed Price · Currency is USD
4.270
0.00 (0.00%)
Dec 19, 2025, 9:30 AM EST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $742.25 million as of December 22, 2025. Its market cap has increased by 133.72% in one year.
Market Cap
742.25M
Enterprise Value
803.84M
Revenue
211.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.27
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 133.86M to 742.25M, an increase of 454.49%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 717.19M | 97.30% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | 862.29M | 228.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |